Ligand profile
CQX
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_20485 — Cytochrome o ubiquinol oxidase subunit 3
Identifiers
Database identifiers and provenance.
- Ligand ID
CQX- PDB
6jy3- UniProt (similar protein)
P00415- Target protein
- KP13_20485
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 108.6
- −1 ≤ LogP ≤ 5 0.96
- MW ≤ 500 Da 364.5
- LogP ≤ 5 0.96
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 14
- TPSA ≤ 140 Ų 108.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCCCCOCCO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)OCCCCCCCCCCOCCO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
InChI=1S/C18H36O7/c1-2-3-4-5-6-7-8-9-10-23-11-12-24-18-17(22)16(21)15(20)14(13-19)25-18/h14-22H,2-13H2,1H3/t14-,15-,16+,17+,18+/m1/s1InChI=1S/C18H36O7/c1-2-3-4-5-6-7-8-9-10-23-11-12-24-18-17(22)16(21)15(20)14(13-19)25-18/h14-22H,2-13H2,1H3/t14-,15-,16+,17+,18+/m1/s1
VOSUWWUWOMLIMI-ZBRFXRBCSA-NVOSUWWUWOMLIMI-ZBRFXRBCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00115' 'PF02790' 'PF02937
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CQX →
- PDB RCSB structure 6jy3 →
- UniProt UniProt P00415 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CQX”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_20485.
PDB 29
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).